Valuation (57%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 21.49 | 16.61 |
PEG Ratio (TTM) | 12.68 | 2.09 |
P/S Ratio (TTM) | 0.87 | 1.47 |
P/B Ratio (TTM) | 1.62 | 2.77 |
P/FCF Ratio (TTM) | 13.07 | 10.56 |
Price to 5YR AVG Earnings Ratio | -15.28 | 2.74 |
Price to 5YR AVG FCF Ratio | 27.70 | 33.45 |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 4.45% | 7.81% |
ROE (TTM) | 7.67% | 18.55% |
Net Profit Margin (TTM) | 4.05% | 10.37% |
ROIC 5YR AVG | -9.24% | 6.27% |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 71.15% | -3,082.94% | -1,807.17% |
Revenue | -1.15% | -14.10% | 10.68% |
Net Income | 70.80% | -3,271.38% | -1,912.62% |
Cash Flow | 7.53% | -58.57% | 177.50% |
Health (63%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.78 | 1.88 |
Quick Ratio (TTM) | 1.62 | 1.36 |
D/E Ratio (TTM) | 0.12 | 1.00 |
Interest Coverage (TTM) | 12.37 | 17.33 |
Piotroski F-Score | 7 | 7 |
Altman Z-Score | 2.87 | 2.93 |
LTL to 5YR AVG FCF | 0.82 | 8.50 |
Shares Outstanding Growth 5YR AVG | 9.89% | 5.48% |